BioArtis

Hyderabad, India Founded: 2014 • Age: 12 yrs
Life sciences kits and reagents are developed for molecular diagnostics.
Annual revenue $4,598 Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About BioArtis

BioArtis is a company based in Hyderabad (India) founded in 2014. BioArtis operates in a competitive market with competitors including Abcam, Stem Cell Technologies, Meridian Bioscience, Teknova and Sangon Biotech, among others.

  • Headquarter Hyderabad, India
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Legal Name Bioartis Life Sciences Private Limited
  • Date of Incorporation 03 Jul, 2014
  • Jurisdiction Hyderabad, Telangana, India
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $4.6 K (USD)
    0
    as on Mar 31, 2016
  • Net Profit
    $52.31 (USD)
    0
    as on Mar 31, 2016
  • EBITDA
    -$81.95 (USD)
    0
    as on Mar 31, 2016
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of BioArtis

Premium access

Detailed funding history for BioArtis

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by BioArtis

Investments
Premium access

Investment portfolio details for BioArtis

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - BioArtis

Premium access

Detailed financials for BioArtis

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Bioartis Comparisons

BioArtis Primary company
Description
Life sciences kits and reagents are developed for molecular ...
Location
Hyderabad, India
Founded Year
2014
Annual Revenue
$4.6 K (USD)
Net Profit
$52.31 (USD)
EBITDA
-$81.95 (USD)
Employees
Not available
Premium access

Peer comparison for BioArtis

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of BioArtis

BioArtis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Stem Cell Technologies, Meridian Bioscience, Teknova and Sangon Biotech, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Biological reagents and antibodies are developed for life science research.
Locked Locked Locked
Developer of cell culture media and ancillary reagents for life science research
Locked Locked Locked
Molecular diagnostic device and kits
Locked Locked Locked
Molecular biology reagents and kits are supplied for research applications.
Locked Locked Locked
Research services, reagents, and kits for biotech applications are provided.
Locked Locked Locked
Bioreagents and assay kits are developed, with preclinical services provided.
Premium access

Detailed competitors of BioArtis

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Bioartis

Premium access

Complete news archive for BioArtis

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about BioArtis

BioArtis was founded in 2014.

BioArtis is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Nasar Khaja is the current CEO of BioArtis.

Annual revenue of BioArtis is $4.6K as on Mar 31, 2016.

BioArtis was founded in 2014 and is based in Hyderabad, India. Operations focus on the life sciences sector, where molecular diagnostic kits are manufactured for pathogen detection in humans and animals. Techniques such as Nested PCR are included in the product range. Reagents and kits support research and diagnostic applications in veterinary and human health fields.

BioArtis's top competitors include Abcam, Meridian Bioscience and Stem Cell Technologies.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available